Safety and toxicity of nanomaterials in ophthalmology diseases In recent years, the employment of nanomaterials has emerged as a promising strategy for addressing and diagnosing a wide array of ophthalmic disorders
Our team streamlines the enrollment process, managing all paperwork, collaborating with your healthcare providers, and delivering completed applications to the manufacturer
~ AlphaMD Most men walk into a doctor's office, get asked how they're feeling, and say something like "tired, kind of off, not myself." The doctor nods, orders a few labs, and the appointment ends with everyone feeling like something important went unsaid
Now, researchers are asking a bigger question: could these medications also influence breast cancer risk, treatment tolerance, or long-term outcomes
September 5th, 2025: Research Suggests GLP-1 Medications May Raise Kidney Cancer Risk Amid Growing Litigation A new study published in JAMA Oncology suggests that GLP-1 receptor agonists such as Ozempic and Mounjaro could increase the risk of kidney cancer, despite appearing to lower the risk of certain other cancers